Suboptimal therapy following breast conserving surgery in triple-negative and HER2-positive breast cancer patients. Johnson JE, Strassle PD, de Oliveira GC, Agala CB, et al. Breast Cancer Res Treat 2021 Jun 26. pii: 10.1007/s10549-021-06303.

Read + Share

Amedeo Smart

Independent Medical Education

Johnson JE, Strassle PD, de Oliveira GC, Agala CB, et al. Suboptimal therapy following breast conserving surgery in triple-negative and HER2-positive breast cancer patients. Breast Cancer Res Treat 2021 Jun 26. pii: 10.1007/s10549-021-06303.
PMID: 34176085